Navigation Links
Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
Date:9/28/2007

CALGARY, Sept. 28 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced that an oral presentation covering interim results from a U.K. Phase Ia/Ib combination REOLYSIN(R) and radiation clinical trial for patients with advanced or metastatic cancers is scheduled to be presented at the National Cancer Research Institute (NCRI) conference on October 2, 2007 in Birmingham, U.K. The presentation, entitled "Biological Approaches to Radiosensitisation: Viruses, Gene Therapy and Novel Radiosensitisers" will be presented by Dr. Kevin Harrington of The Institute of Cancer Research, London and one of the principal investigators for the trial. The conference runs from September 30 through October 3, 2007 in Birmingham, U.K.

"We are very pleased with the results of this trial to date," said Dr. Brad Thompson, President and CEO of Oncolytics. "We continue to evaluate the data and look forward to announcing final results."

To date, 22 patients have been treated with 15 having completed the study. Five patients withdrew from the study, and two patients are still on study.

A total of 11 patients in the Ia portion of the trial received two intratumoural treatments of REOLYSIN(R) at dosages of 1x10(8), 1x10(9), or 1x10(10) TCID(50) with a constant localized radiation dose of 20 Gy given in five fractions. Of these 11 patients, three patients (oesophageal, squamous skin carcinoma and squamous cell scalp) experienced significant partial responses.

One month following treatment, the oesophageal patient experienced a 28.5% reduction in the target tumour, with stable disease noted in four, non-treated tumours. At two and three months, the target tumour had shrunk 64%, with stable disease continuing in the four non-treated tumours, including a 15% volume reduction in non-treated mediastinal disease that was maintained for more than six months. The squamous skin cancer patient experienced a 50% reduction in the t
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. The state of global biotech: An Ernst & Young perspective
2. Olympics of biotechnology has international flavor
3. Biotech officials praise focus of new venture fund
4. Getting noticed in Genetown: Wisconsin biotech on display
5. Madison biotech NimbleGen files for IPO; one of states best-funded firms
6. Wisconsin biotech firm receives $107K NIH grant
7. Biotech executive books a career flight thats closer to home
8. Manufacturing partnership will move into biotech and biomedical spaces
9. Wisconsin wont get Georgia biotech without a fight
10. The 10 biggest events shaping biotech in 2006
11. Gala Biotech among companies sold for $3.3 billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 2014  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... of regenerative medicine, today announced that the Company,s ... complete cervical spinal cord injury (SCI), has been ... Projects to Watch" by Elsevier Business Intelligence. ... industry honor, which represents independent validation of the ...
(Date:11/17/2014)... The new METTLER TOLEDO White Paper " Traceability ... becoming the first calibration laboratory in the world ... the microgram range. National Metrology Institutes (NMI's), private ... in nanotechnology applications will benefit from understanding the ... weights in the range of 0.05 mg to ...
(Date:11/16/2014)... (PRWEB) November 16, 2014 James Hill ... With Filtered Fume Hoods, 3 Years Later” scheduled for ... fall of 2011, Butler University surprised many in the ... in their organic chemistry and general chemistry teaching laboratories ... due to building age and substantial growth within the ...
(Date:11/15/2014)... FL (PRWEB) November 14, 2014 ... scientifically validated physical activity and sleep measurement platform ... improved subject experience along with multiple new channels ... and secondary accelerometer. Equipped with Bluetooth Smart technology, ... capture and mobile data uploads to ActiGraph’s cloud-based ...
Breaking Biology Technology:Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" and Will Present at the Therapeutic Area Partnerships Conference 2Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" and Will Present at the Therapeutic Area Partnerships Conference 3New White Paper on Microgram Weights Describes How to Achieve Traceable Measurement Down to 0.05 Milligrams 2Don't miss the I2SL High-Tech Talks Webinar Series Presenting: Butler University's Renovation With Filtered Fume Hoods, 3 Years Later 2Don't miss the I2SL High-Tech Talks Webinar Series Presenting: Butler University's Renovation With Filtered Fume Hoods, 3 Years Later 3ActiGraph Launches GT9X Link Activity Monitor 2
... , ... combines many of Haydon Kerk’s patented motion technologies into a single integrated system. ... simplifying product integration for the OEM. , ... Waterbury, CT (PRWEB) June 21, 2010 -- Haydon Kerk Motion ...
... ... facility as part of the Utah Science Technology and Research (USTAR) project on the U of U ... Salt Lake City, Utah (Vocus) June 19, ... firms in the U.S., is assisting in the construction of a new USTAR facility at the University ...
... The Reproductive Health Drugs Advisory Committee met today to discuss the ... Hypoactive Sexual Desire Disorder (HSDD) in pre-menopausal women.  The advisory committee was ... (FDA).  The FDA will consider the committee,s advice as part of its ... , , ...
Cached Biology Technology:Haydon Kerk Motion Solutions Introduces the RGS04 Dual Carriage Linear Rail and Programmable Actuator Assembly 2Bigge Helps Build New USTAR Complex at the University of Utah 2
(Date:11/5/2014)... professor of biology in the UTSA College of ... nation selected to receive a two-year $300,00 National ... Research (EAGER). The funding supports President Obama,s BRAIN ... create new technology that will demystify complex brain ... in neuroscience are broken into the interactions of ...
(Date:11/4/2014)... Medicine announced today that it is a Grand ... Bill & Melinda Gates Foundation. Laura Goetzl, ... Sciences; and Vice Chair of Research and Academic ... pursue an innovative global health and development research ... Neurodevelopment.", Grand Challenges Explorations (GCE) funds individuals worldwide ...
(Date:11/4/2014)...   Neurotechnology , a provider of high-precision ... version of its fingerprint matching algorithm has achieved ... evaluation organized by NIST. The MINEX test measures ... 378 fingerprint standard template format. MINEX compliance is ... the United States and ...
Breaking Biology News(10 mins):UTSA biology professor awarded $300,000 NSF grant for brain research 2UTSA biology professor awarded $300,000 NSF grant for brain research 3Temple University School of Medicine receives Grand Challenges Explorations grant 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 3
... living sensor that can spot contamination. They have also ... even in previously untreatable cold areas, microbiologists heard today ... Microbiology,s Autumn meeting being held this week at Trinity ... in the sub-arctic. It contains over 230,000 tonnes of ...
... a new method to fabricate borosilicate glass ... nanoparticles are more stable when subjected to ... currently used nanoparticles made of polymers or ... range of potential nanoparticle applications in biomedical, ...
... MD The Biophysical Society is pleased to announce ... recipients will receive their awards at the Society,s 53rd ... Boston Convention and Exhibitions Center in Massachusetts. The awardees ... California, San Francisco, will receive the Anatrace Membrane Protein ...
Cached Biology News:Living sensor can warn of arsenic pollution 2Biophysical Society names 2009 award recipients 2
... min) assay can detect H2O2 or peroxidase ... H2O2 oxidizes ADHP in a 1:1 stoichiometry ... at 530-571 nm, emission at 590-600 nm). ... a one-step, homogeneous, no wash assay system. ...
...
Rabbit polyclonal to Staphylococcus Enterotoxin A (HRP) ( Abpromise for all tested applications)....
... better net results - with a modular ... data management! The ChemStation Plus NDS family ... data acquisition and data management, giving you ... meets your labs needs now and that ...
Biology Products: